Announcing a new publication for Acta Materia Medica journal. Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic ...

May 13 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it is starting a process to remove fluoride supplements for children from the market, the latest federal action against the ...

Therapeutic options include incision and drainage in combination with antimicrobial therapy, which may be oral, topical or occasionally parenteral. Because the effectiveness of the current oral ...

It is the first US approval for a topical gene therapy, according to the regulator, which has said Vyjuvek (beremagene geperpavec) can be used to treat patients aged six months of over who have ...

The strengths are as follows: One strip contains 50 micrograms (mcg), 100 mcg, or 200 mcg of fluticasone furoate per blister. The other strip contains 25 mcg of vilanterol per blister. A blister ...

Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate) is a prescription drug used to treat COPD. It comes with an inhaler device for breathing the drug into your lungs. You’ll ...

Credit: Eligo Bioscience. Biotechnology company Eligo Bioscience has obtained a $5m grant from the French Government to expedite the development and upscaling of its topical gene delivery platform.

HealthDay News — For children using fluticasone propionate, the withdrawal of the brand-name drug (Flovent) was associated with increased discontinuation of inhaled steroid therapy, according to a ...

Panelists discuss how steroid dosing for chronic graft-vs-host disease (cGVHD) typically starts at 0.5-1 mg/kg/day depending on severity, with careful tapering to avoid flares.

Treatment for two weeks with either oral prednisolone (30 mg/day), high dose fluticasone propionate (2000 μg/day, FP2000), or lower dose FP (500 μg/day, FP500), both given by a dry powder inhaler, ...

MINNEAPOLIS — Fewer than half of women treated for high-grade cervical dysplasia subsequently received guidance-concordant surveillance, of whom one-third had an abnormal co-test result ...